Clinical Trial Update: Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis [NA]

View source ↗

Summary

An ongoing clinical trial at Semmelweis University is evaluating optimal treatment strategies for restenosis after coronary drug-eluting stent implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• In-stent Restenosis

Snippet

Sponsor: Semmelweis University Heart and Vascular Center | Conditions: Coronary Stent Restenosis | NA | Status: RECRUITING